Business Wire

Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced ...
American Institute of Physics

Personalized electrode placement for spinal cord injury rehabilitation

Automatic personalization of electrode placement for transcutaneous spinal cord stimulation can take it to the next level.
Business Wire

Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association

MIAMI--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced ...
Seeking Alpha

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

EDEN PRAIRIE, Minn., Sept. 24, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care ...